We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.05 | 2.00 | 2.10 | 2.05 | 2.05 | 2.05 | 1,009,938 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.39 | 15.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
13/10/2023 13:08 | It WILL be in the price once all the mugs have been shaken out. | the imperialist | |
13/10/2023 11:55 | You say that next set of results are going to be good perhaps you might consider that this maybe already in the price.. | hamidahamida | |
13/10/2023 10:51 | an interesting article to read: Welcome back to our Ingredient Highlight! This month, we're shining a spotlight on a truly magical mineral: iron and its potential benefits for individuals with ADHD. Iron is an essential mineral crucial for various bodily functions, including the production of haemoglobin, which carries oxygen in the blood. But what does this have to do with ADHD? A study published in the Journal of Attention Disorders in 2022 titled "Iron Deficiency and its Impact on Attention Deficit Hyperactivity Disorder" delves into the fascinating relationship between iron deficiency and ADHD. The study found that individuals with lower iron levels were more likely to exhibit ADHD symptoms, including difficulty concentrating, impulsivity, and hyperactivity. The research suggests that maintaining adequate iron levels in the body may help mitigate the symptoms of ADHD and improve cognitive function. Iron is involved in the production of dopamine and norepinephrine, two neurotransmitters that play a crucial role in regulating attention and impulse control. | qipincha | |
13/10/2023 09:47 | If it's true, that STX have the number of, and engage with, the manager of a £300 portfolio, I will sell-up today. | the imperialist | |
13/10/2023 09:46 | I just shared that with my wife, an English teacher. Oh how she chuckled. Thanks Ammo. | the imperialist | |
13/10/2023 09:23 | I've shared your post with the company Ammo. Will keep you updated. | the imperialist | |
13/10/2023 09:20 | If you live in US, you know the salary won’t be 50k per year… | qipincha | |
13/10/2023 08:15 | My typo - acquisition. . Time to buy at a bonkers discount | rollercoasterrider | |
13/10/2023 07:30 | 100% Correct. Avoid the noise. Buy and hold. We know the next set of results will be good, they've already told us. We'll rise into those results. Just waiting for the turn. DYOR | the imperialist | |
13/10/2023 07:24 | CFOs can leave for a number of reasons one of which is an impending question attempt at a discounted price. This is now trading significantly below fair value. | rollercoasterrider | |
12/10/2023 20:26 | Patt ramped enet all the way down to bust.STX is next 😅 | normawoods | |
12/10/2023 20:19 | is any share impacted by your thoughts patt ? | arab3 | |
12/10/2023 20:09 | Strangely STX is not impacted by me. I think revenues will rise fast and gross margins improve. But who knows? | purchaseatthetop | |
12/10/2023 20:05 | Why would STX be next? Another uneducated bellend | zeus19 | |
12/10/2023 19:19 | Patts enet is gone bust, will stx be next😅 | normawoods | |
12/10/2023 18:20 | Sad really, a very promising Company some years ago, so many poor management around these days but are they really that bothered, a nice comfy salary with bonuses etc just the shareholder that gets shafted in the end. | ny boy | |
12/10/2023 18:02 | Skots we all know that the previous management(s) made huge balls-ups and wasted years (and millions of investors' money). The problem is that confidence has been shaken in the latest team because they promised they had enough after the last fundraise, and now they've had to raise another $20m in a very expensive and onerous loan to keep going. They also don't seem to have fully understood the GTN issue early enough. So risks have increased here, despite the rocketing Rx numbers. That's why confidence has been shaken in the short term. But it's still all to play for, and 6p is dirt cheap, *if* you believe that Shield will genuinely break even by Xmas 24. | cyberbub | |
12/10/2023 17:41 | I've never quite understood your pathological dislike of Maddison and your 100% confidence in the boring CFO. They're the same team, made the same joint decisions with the board (well maybe until now). And the board has backed the CEO and not the CFO.And those who have been here for eons know that the current management have been fire fighting since the monumental screw up of the prior two CEOsThe business is growing but they've been short of money since the other two failed to get a partner and then royally screwed up the go it alone strategy | skcots48 | |
12/10/2023 17:10 | Rudolf was probably left with a red nose following the fiasco of the past week and collapse in share price Did he walk or was he pushed ? | wheeze | |
12/10/2023 16:23 | Really guys! This CEO took over at 57p+. Asked for 2yrs and 2yrs later now at 6p. At that time I asked for their lawyers to get rid of him then as simply looked superficial to me. They would not provide. Which one of us is right so far!!. Every time this share price starts to improve he will pursue more loans. There is no-one now to stop him now the CFO has gone. The product is great but this is a bad mix. The bard stood by and let this happen and rewarded the CEO with shares!! Time for a takeover if ever there was one!! | bolitix |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions